PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Biomarker Development, Novartis Institutes for BioMedical Research, 220 Massachusetts Ave, Cambridge, MA 02139, USA.\', \'Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, 250 Massachusetts Ave, Cambridge, MA 02139, USA.\', \'Biopharmaceutical Industry Fellowship Program, Massachusetts College of Pharmacy & Health Sciences University, 179 Longwood Ave, Boston, MA 02115, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.4155/bio-2020-0063
?:doi
?:hasPublicationType
?:journal
  • Bioanalysis
is ?:pmid of
?:pmid
?:pmid
  • 32686955
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.793
?:rankingScore_hIndex
  • 46
?:title
  • Evaluation of a novel blood microsampling device for clinical trial sample collection and protein biomarker analysis.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32686955>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32686955>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all